GMFCS Level III at Age 4 - Walking Independently: Key Clinical Points

Understanding the Discrepancy

• Capable of walking using a hand-held mobility device
• May self-propel a manual wheelchair at school
• Outdoors and in the community, transported in a wheelchair or powered mobility

1. The GMFCS level may have been assigned earlier and the child is progressing well
2. They may be functioning closer to Level II now (re-assessment indicated)
3. The GMFCS is designed to be stable - if re-evaluation confirms Level III, walking will likely become more device-dependent over time

The GMFCS is a reliable and stable method of classification and prediction of motor function for children under age 12. It has been validated with good-to-excellent interrater reliability. - Campbell's Operative Orthopaedics 15th Ed 2026

Gross Motor Prognosis

Associated Comorbidities to Monitor

• Risk is directly correlated with GMFCS level
• GMFCS III carries meaningful hip subluxation/dislocation risk (compared to near-0% for Level I)
• Radiographic changes typically appear between 2-4 years of age - this child is exactly in that window
• Hip surveillance is mandatory: AP pelvis X-ray to measure the Migration Percentage (Reimers index) now, and repeated every 6-12 months depending on findings
• Pain affects up to 47% of young adults with CP; early detection is protective

"Risk of hip dislocation is directly related to GMFCS level, with a nearly 0% incidence for GMFCS I patients and 90% for GMFCS V patients." - Campbell's Operative Orthopaedics 15th Ed 2026

• GMFCS I and II have almost no risk; risk rises significantly at III and above
• Annual spine screening recommended

• Common in spastic CP; may present subtly initially
• Contributes to toe-walking and crouch gait progression

• A major concern for GMFCS III children - hip flexion contracture, hamstring tightness, and ankle plantarflexor weakness combine to worsen gait as the child grows
• Hamstring and hip flexor spasticity should be monitored serially

Management Priorities at Age 4

Physiotherapy

• Intensive physical therapy for strength, balance, and functional motor skills
• Focus on gait training - maximize the developmental window before the plateau
• Stretching programs for lower extremity muscle groups (hamstrings, hip flexors, ankle plantarflexors)
• Constraint-induced movement therapy if hemiplegia component present

Orthoses

• Ankle-Foot Orthoses (AFOs) - typically solid or hinged AFO to control equinus and support gait mechanics
• Orthoses should be prescribed and reviewed by an orthotist in conjunction with the physiotherapist

Spasticity Management

• Botulinum toxin A (BoNT-A) injections: First-line for focal spasticity (e.g., gastrocnemius, hamstrings, hip adductors). Effective for improving range of motion and reducing deformity progression; often combined with serial casting
• Oral baclofen: Used when widespread spasticity is present, but systemic side effects (sedation, cognitive effects) limit use - especially important to avoid in an ambulatory child
• Intrathecal baclofen (ITB): Generally reserved for GMFCS IV-V with severe diffuse spasticity; risks include pump infection, over-sedation reducing ambulation
• Selective Dorsal Rhizotomy (SDR): Can be considered in carefully selected spastic diplegic children (typically GMFCS II-III); best outcomes with good cognitive function, isolated spasticity, and adequate underlying strength. Usually deferred until age 3-8

Orthopaedic Surveillance / Intervention Timing

• A key principle: delay surgery until after significant growth spurts where possible to reduce recurrence
• Children with CP have skeletal age approximately 2 years advanced compared to chronologic age (highest correlation found in boys with GMFCS Level III) - factor this into surgical timing
• Single-event multilevel surgery (SEMLS) when multiple lower limb deformities require correction: typically deferred to age 6-8+ when gait pattern has matured
• Monitor for equinus - Achilles tendon lengthening is common but timing matters

Communication and Cognition

• Assess for associated impairments: epilepsy (~30-40%), intellectual disability, visual impairment, dysarthria, dysphagia
• Augmentative and Alternative Communication (AAC) if speech is affected
• Early educational support and occupational therapy for activities of daily living

Multidisciplinary Team

• Developmental Paediatrician / Paediatric Neurologist
• Paediatric Orthopaedic Surgeon
• Physiotherapist (regular, ongoing)
• Occupational Therapist
• Orthotist
• Speech-Language Pathologist (assess for dysphagia/communication)
• Social work / family support

A Practical Note on Re-assessment

• Level II at age 4 predicts likely community ambulation as an adult
• Level III at age 4 predicts likely household ambulation with mobility device for distances

"This five-level grading system has been found to be a reliable and stable method of classification and prediction of motor function for children under the age of 12 years." - Campbell's Operative Orthopaedics 15th Ed 2026